Anti-epilepsy drug restores normal brain activity in mild Alzheimer's disease

(Beth Israel Deaconess Medical Center) In a recent feasibility study, BIDMC tested an anti-epileptic drug for its potential impact on the brain activity of patients with mild Alzheimer's disease. The team documented changes in patients' EEGs that suggest the drug could have a beneficial effect.